Sintx Technologies (SINT) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.16% |
| Dec 31, 2025 | -24.78% |
| Sep 30, 2025 | -27.11% |
| Jun 30, 2025 | -54.92% |
| Mar 31, 2025 | -38.63% |
| Dec 31, 2024 | -55.61% |
| Sep 30, 2024 | -47.79% |
| Jun 30, 2024 | -35.95% |
| Mar 31, 2024 | -37.75% |
| Dec 31, 2023 | 53.79% |
| Sep 30, 2023 | 13.52% |
| Jun 30, 2023 | 14.62% |
| Mar 31, 2023 | 10.33% |
| Dec 31, 2022 | -66.83% |
| Sep 30, 2022 | -51.06% |
| Jun 30, 2022 | -43.90% |
| Mar 31, 2022 | -38.76% |
| Dec 31, 2021 | -33.36% |
| Sep 30, 2021 | -30.13% |
| Jun 30, 2021 | 11.89% |
| Mar 31, 2021 | 110.55% |
| Dec 31, 2020 | 396.04% |
| Sep 30, 2020 | 356.80% |
| Jun 30, 2020 | 198.07% |
| Mar 31, 2020 | 65.55% |
| Dec 31, 2019 | -38.06% |
| Sep 30, 2019 | -25.49% |
| Jun 30, 2019 | -43.05% |
| Mar 31, 2019 | 13.10% |
| Dec 31, 2018 | 54.34% |
| Sep 30, 2018 | 77,390.42% |
| Jun 30, 2018 | 92,090.43% |
| Mar 31, 2018 | 42,930.70% |
| Dec 31, 2017 | -51.56% |
| Sep 30, 2017 | -99.91% |
| Jun 30, 2017 | -99.87% |
| Dec 31, 2016 | -21.61% |
| Sep 30, 2016 | 769.95% |
| Jun 30, 2016 | 19.51% |
| Dec 31, 2015 | 107.50% |
| Sep 30, 2015 | -114.36% |
| Jun 30, 2015 | -45.09% |
| Mar 31, 2015 | -84.45% |
| Dec 31, 2014 | 104.51% |